SCYXNasdaqPharmaceutical PreparationsFiscal year ends December 31
SCYNEXIS INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$3.66−0.01 (-0.27%)
Close on Oct 19, 2026
- Market cap
- $43.28M
- P/E (TTM)
- –
- Dividend yield
- –
Fundamental chart
Pick a measure to chart its full history
$20.60MFY2025, +1.7% a year since FY2013